Novel fused isoquinolines as dopamine receptor ligands

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 221/18 (2006.01) A61K 31/47 (2006.01) A61K 31/695 (2006.01) C07D 401/12 (2006.01) C07D 405/12 (2006.01) C07D 491/056 (2006.01) C07F 7/10 (2006.01)

Patent

CA 2227585

The present invention is directed to novel dopamine receptor ligands of formula (I), pharmaceutical formulations of such compounds, and a method using such compounds for treating a patient suffering from dopamine-related dysfunction of the central or peripheral nervous system.

L'invention se rapporte à des nouveaux ligands pour récepteurs de la dopamine, représentés par la formule (I), les formulations pharmaceutiques de ces composés, et un procédé dans lequel ces composés sont utilisés pour traiter un patient souffrant d'un dysfonctionnement du système nerveux périphérique ou central, lié à la dopamine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel fused isoquinolines as dopamine receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel fused isoquinolines as dopamine receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel fused isoquinolines as dopamine receptor ligands will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1499952

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.